Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein

Jie Zhang, Ilya Frolov, Stephen J Russell

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background. Malignant glioma has a dismal prognosis. It was previously shown that glioma cells are efficiently killed when they express a gene coding for a hyperfusogenic mutant of the gibbon ape leukemia virus envelope glycoprotein (GALV.fus). However, production of viral vectors expressing GALV.fus has proven problematic because the transgene is toxic to vector-producing cells of human origin. We reasoned that Sindbis-virus-based vectors might be ideal for GALV.fus gene transfer because high-titer stocks can easily be generated in hamster cells and Sindbis virus efficiently infects human tumor cells through the high-affinity 67 kDa laminin receptor. In addition, Sindbis virus nonstructural proteins are potent inducers of apoptosis, and Sindbis vector RNAs expressing fusogenic viral proteins have been shown to spread from cell-to-cell in membrane-formed infectious particles. Methods. Sindbis virus replicon-containing particles were generated by cotransfecting vector and helper RNAs into baby hamster kidney (BHK-21) cells. Packaged beta-galactosidase and GALV.fus expressing Sindbis vectors were used to infect glioma cell lines, which were then compared for syncytial cytopathic effect, cell killing, and release of infectious virus-like particles containing the vector genome. Finally, the efficacy of GALV.fus and beta-galactosidase Sindbis vectors was compared in an orthotopic intracerebral U87 glioma xenograft model in nude mice. Results. High-titer stocks (>109 infectious units (iu)/ml) of the GALV.fus and beta-galactosidase vectors were obtained. Glioma cells infected with the GALV.fus vector formed large syncytia which died rapidly by apoptosis and released infectious membrane-formed particles that could transfer vector genomes to uninfected cells. The GALV.fus vector had significantly greater antitumor therapeutic potency than the β-galactosidase vector in the U87 glioma xenograft model. Conclusions. Sindbis vectors expressing GALV.fus can be packaged into infectious viral particles to high titer, they exhibit potent bystander cytopathic potential and are active against U87 glioma xenografts. Sindbis-virus-based replicons appear to be efficient vector systems for delivery and expression of fusogenic membrane glycoproteins.

Original languageEnglish (US)
Pages (from-to)1082-1091
Number of pages10
JournalJournal of Gene Medicine
Volume6
Issue number10
DOIs
StatePublished - Oct 2004

Fingerprint

Gibbon ape leukemia virus
Membrane Glycoproteins
Glioma
Genetic Therapy
Sindbis Virus
beta-Galactosidase
Heterografts
Replicon
Cricetinae
Virion
Galactosidases
Laminin Receptors
Genome
RNA
Apoptosis
Poisons
Viral Proteins
Giant Cells
Transgenes
Nude Mice

Keywords

  • Alphavirus vectors
  • Fusogenic membrane glycoproteins
  • Glioma
  • Sindbis virus
  • Syncytia
  • Virus-like particles

ASJC Scopus subject areas

  • Genetics

Cite this

Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. / Zhang, Jie; Frolov, Ilya; Russell, Stephen J.

In: Journal of Gene Medicine, Vol. 6, No. 10, 10.2004, p. 1082-1091.

Research output: Contribution to journalArticle

@article{0b796411cbd44189b3398fdab978270a,
title = "Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein",
abstract = "Background. Malignant glioma has a dismal prognosis. It was previously shown that glioma cells are efficiently killed when they express a gene coding for a hyperfusogenic mutant of the gibbon ape leukemia virus envelope glycoprotein (GALV.fus). However, production of viral vectors expressing GALV.fus has proven problematic because the transgene is toxic to vector-producing cells of human origin. We reasoned that Sindbis-virus-based vectors might be ideal for GALV.fus gene transfer because high-titer stocks can easily be generated in hamster cells and Sindbis virus efficiently infects human tumor cells through the high-affinity 67 kDa laminin receptor. In addition, Sindbis virus nonstructural proteins are potent inducers of apoptosis, and Sindbis vector RNAs expressing fusogenic viral proteins have been shown to spread from cell-to-cell in membrane-formed infectious particles. Methods. Sindbis virus replicon-containing particles were generated by cotransfecting vector and helper RNAs into baby hamster kidney (BHK-21) cells. Packaged beta-galactosidase and GALV.fus expressing Sindbis vectors were used to infect glioma cell lines, which were then compared for syncytial cytopathic effect, cell killing, and release of infectious virus-like particles containing the vector genome. Finally, the efficacy of GALV.fus and beta-galactosidase Sindbis vectors was compared in an orthotopic intracerebral U87 glioma xenograft model in nude mice. Results. High-titer stocks (>109 infectious units (iu)/ml) of the GALV.fus and beta-galactosidase vectors were obtained. Glioma cells infected with the GALV.fus vector formed large syncytia which died rapidly by apoptosis and released infectious membrane-formed particles that could transfer vector genomes to uninfected cells. The GALV.fus vector had significantly greater antitumor therapeutic potency than the β-galactosidase vector in the U87 glioma xenograft model. Conclusions. Sindbis vectors expressing GALV.fus can be packaged into infectious viral particles to high titer, they exhibit potent bystander cytopathic potential and are active against U87 glioma xenografts. Sindbis-virus-based replicons appear to be efficient vector systems for delivery and expression of fusogenic membrane glycoproteins.",
keywords = "Alphavirus vectors, Fusogenic membrane glycoproteins, Glioma, Sindbis virus, Syncytia, Virus-like particles",
author = "Jie Zhang and Ilya Frolov and Russell, {Stephen J}",
year = "2004",
month = "10",
doi = "10.1002/jgm.605",
language = "English (US)",
volume = "6",
pages = "1082--1091",
journal = "Journal of Gene Medicine",
issn = "1099-498X",
publisher = "John Wiley and Sons Ltd",
number = "10",

}

TY - JOUR

T1 - Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein

AU - Zhang, Jie

AU - Frolov, Ilya

AU - Russell, Stephen J

PY - 2004/10

Y1 - 2004/10

N2 - Background. Malignant glioma has a dismal prognosis. It was previously shown that glioma cells are efficiently killed when they express a gene coding for a hyperfusogenic mutant of the gibbon ape leukemia virus envelope glycoprotein (GALV.fus). However, production of viral vectors expressing GALV.fus has proven problematic because the transgene is toxic to vector-producing cells of human origin. We reasoned that Sindbis-virus-based vectors might be ideal for GALV.fus gene transfer because high-titer stocks can easily be generated in hamster cells and Sindbis virus efficiently infects human tumor cells through the high-affinity 67 kDa laminin receptor. In addition, Sindbis virus nonstructural proteins are potent inducers of apoptosis, and Sindbis vector RNAs expressing fusogenic viral proteins have been shown to spread from cell-to-cell in membrane-formed infectious particles. Methods. Sindbis virus replicon-containing particles were generated by cotransfecting vector and helper RNAs into baby hamster kidney (BHK-21) cells. Packaged beta-galactosidase and GALV.fus expressing Sindbis vectors were used to infect glioma cell lines, which were then compared for syncytial cytopathic effect, cell killing, and release of infectious virus-like particles containing the vector genome. Finally, the efficacy of GALV.fus and beta-galactosidase Sindbis vectors was compared in an orthotopic intracerebral U87 glioma xenograft model in nude mice. Results. High-titer stocks (>109 infectious units (iu)/ml) of the GALV.fus and beta-galactosidase vectors were obtained. Glioma cells infected with the GALV.fus vector formed large syncytia which died rapidly by apoptosis and released infectious membrane-formed particles that could transfer vector genomes to uninfected cells. The GALV.fus vector had significantly greater antitumor therapeutic potency than the β-galactosidase vector in the U87 glioma xenograft model. Conclusions. Sindbis vectors expressing GALV.fus can be packaged into infectious viral particles to high titer, they exhibit potent bystander cytopathic potential and are active against U87 glioma xenografts. Sindbis-virus-based replicons appear to be efficient vector systems for delivery and expression of fusogenic membrane glycoproteins.

AB - Background. Malignant glioma has a dismal prognosis. It was previously shown that glioma cells are efficiently killed when they express a gene coding for a hyperfusogenic mutant of the gibbon ape leukemia virus envelope glycoprotein (GALV.fus). However, production of viral vectors expressing GALV.fus has proven problematic because the transgene is toxic to vector-producing cells of human origin. We reasoned that Sindbis-virus-based vectors might be ideal for GALV.fus gene transfer because high-titer stocks can easily be generated in hamster cells and Sindbis virus efficiently infects human tumor cells through the high-affinity 67 kDa laminin receptor. In addition, Sindbis virus nonstructural proteins are potent inducers of apoptosis, and Sindbis vector RNAs expressing fusogenic viral proteins have been shown to spread from cell-to-cell in membrane-formed infectious particles. Methods. Sindbis virus replicon-containing particles were generated by cotransfecting vector and helper RNAs into baby hamster kidney (BHK-21) cells. Packaged beta-galactosidase and GALV.fus expressing Sindbis vectors were used to infect glioma cell lines, which were then compared for syncytial cytopathic effect, cell killing, and release of infectious virus-like particles containing the vector genome. Finally, the efficacy of GALV.fus and beta-galactosidase Sindbis vectors was compared in an orthotopic intracerebral U87 glioma xenograft model in nude mice. Results. High-titer stocks (>109 infectious units (iu)/ml) of the GALV.fus and beta-galactosidase vectors were obtained. Glioma cells infected with the GALV.fus vector formed large syncytia which died rapidly by apoptosis and released infectious membrane-formed particles that could transfer vector genomes to uninfected cells. The GALV.fus vector had significantly greater antitumor therapeutic potency than the β-galactosidase vector in the U87 glioma xenograft model. Conclusions. Sindbis vectors expressing GALV.fus can be packaged into infectious viral particles to high titer, they exhibit potent bystander cytopathic potential and are active against U87 glioma xenografts. Sindbis-virus-based replicons appear to be efficient vector systems for delivery and expression of fusogenic membrane glycoproteins.

KW - Alphavirus vectors

KW - Fusogenic membrane glycoproteins

KW - Glioma

KW - Sindbis virus

KW - Syncytia

KW - Virus-like particles

UR - http://www.scopus.com/inward/record.url?scp=13644257013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13644257013&partnerID=8YFLogxK

U2 - 10.1002/jgm.605

DO - 10.1002/jgm.605

M3 - Article

C2 - 15368589

AN - SCOPUS:13644257013

VL - 6

SP - 1082

EP - 1091

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

SN - 1099-498X

IS - 10

ER -